Zuari Agro Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:19 pm

Quick Insight

Zuari Agro Chemicals Ltd, with a share price of ₹338 and a market cap of ₹1,417 Cr., presents an intriguing opportunity in the fertiliser industry. The company's low P/E ratio of 5.57 indicates potential undervaluation, while ROE at 9.28% and ROCE at 12.9% suggest decent profitability. With a healthy OPM of 11% and a satisfactory ICR of 2.51x, the company seems to be managing its operations well. However, its low P/BV ratio of 0.41x raises questions about asset valuation. Overall, Zuari Agro Chemicals Ltd appears to be a fundamentally sound investment option, but further analysis of its borrowing levels and growth prospects is warranted for a comprehensive investment decision.

Competitors of Zuari Agro Chemicals Ltd

All Competitor Stocks of Zuari Agro Chemicals Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:00 am

Below is a detailed analysis of the quarterly data for Zuari Agro Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,246.00 Cr.. The value appears strong and on an upward trend. It has increased from 952.00 Cr. (Mar 2025) to 1,246.00 Cr., marking an increase of 294.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,105.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 920.00 Cr. (Mar 2025) to 1,105.00 Cr., marking an increase of 185.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 141.00 Cr.. The value appears strong and on an upward trend. It has increased from 32.00 Cr. (Mar 2025) to 141.00 Cr., marking an increase of 109.00 Cr..
• For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 3.00% (Mar 2025) to 11.00%, marking an increase of 8.00%.
• For Other Income, as of Jun 2025, the value is 72.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2025) to 72.00 Cr., marking an increase of 11.00 Cr..
• For Interest, as of Jun 2025, the value is 34.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 36.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 154.00 Cr.. The value appears strong and on an upward trend. It has increased from 32.00 Cr. (Mar 2025) to 154.00 Cr., marking an increase of 122.00 Cr..
• For Tax %, as of Jun 2025, the value is 17.00%. The value appears to be increasing, which may not be favorable. It has increased from 16.00% (Mar 2025) to 17.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 127.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 127.00 Cr., marking an increase of 100.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 23.54. The value appears strong and on an upward trend. It has increased from 4.72 (Mar 2025) to 23.54, marking an increase of 18.82.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:42 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:02 pm

Below is a detailed analysis of the balance sheet data for Zuari Agro Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 42.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 42.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,814.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,652.00 Cr. (Mar 2024) to 1,814.00 Cr., marking an increase of 162.00 Cr..
• For Borrowings, as of Mar 2025, the value is 717.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,783.00 Cr. (Mar 2024) to 717.00 Cr., marking a decrease of 1,066.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2,453.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,334.00 Cr. (Mar 2024) to 2,453.00 Cr., marking an increase of 1,119.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 5,026.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,811.00 Cr. (Mar 2024) to 5,026.00 Cr., marking an increase of 215.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 868.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,957.00 Cr. (Mar 2024) to 868.00 Cr., marking a decrease of 1,089.00 Cr..
• For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 19.00 Cr..
• For Investments, as of Mar 2025, the value is 1,425.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,270.00 Cr. (Mar 2024) to 1,425.00 Cr., marking an increase of 155.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,729.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,561.00 Cr. (Mar 2024) to 2,729.00 Cr., marking an increase of 1,168.00 Cr..
• For Total Assets, as of Mar 2025, the value is 5,026.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,811.00 Cr. (Mar 2024) to 5,026.00 Cr., marking an increase of 215.00 Cr..

Notably, the Reserves (1,814.00 Cr.) exceed the Borrowings (717.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Zuari Agro Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 39.17. This value is within the healthy range. It has increased from 23.74 (Mar 24) to 39.17, marking an increase of 15.43.
• For Diluted EPS (Rs.), as of Mar 25, the value is 39.17. This value is within the healthy range. It has increased from 23.74 (Mar 24) to 39.17, marking an increase of 15.43.
• For Cash EPS (Rs.), as of Mar 25, the value is 43.30. This value is within the healthy range. It has decreased from 57.71 (Mar 24) to 43.30, marking a decrease of 14.41.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 441.24. It has decreased from 544.43 (Mar 24) to 441.24, marking a decrease of 103.19.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 441.24. It has decreased from 544.43 (Mar 24) to 441.24, marking a decrease of 103.19.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,054.70. It has decreased from 1,092.65 (Mar 24) to 1,054.70, marking a decrease of 37.95.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 100.48. This value is within the healthy range. It has decreased from 126.87 (Mar 24) to 100.48, marking a decrease of 26.39.
• For PBIT / Share (Rs.), as of Mar 25, the value is 76.34. This value is within the healthy range. It has decreased from 104.33 (Mar 24) to 76.34, marking a decrease of 27.99.
• For PBT / Share (Rs.), as of Mar 25, the value is 36.33. This value is within the healthy range. It has decreased from 54.10 (Mar 24) to 36.33, marking a decrease of 17.77.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 19.17. This value is within the healthy range. It has decreased from 35.17 (Mar 24) to 19.17, marking a decrease of 16.00.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 39.17. This value is within the healthy range. It has increased from 23.74 (Mar 24) to 39.17, marking an increase of 15.43.
• For PBDIT Margin (%), as of Mar 25, the value is 9.52. This value is below the healthy minimum of 10. It has decreased from 11.61 (Mar 24) to 9.52, marking a decrease of 2.09.
• For PBIT Margin (%), as of Mar 25, the value is 7.23. This value is below the healthy minimum of 10. It has decreased from 9.54 (Mar 24) to 7.23, marking a decrease of 2.31.
• For PBT Margin (%), as of Mar 25, the value is 3.44. This value is below the healthy minimum of 10. It has decreased from 4.95 (Mar 24) to 3.44, marking a decrease of 1.51.
• For Net Profit Margin (%), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 5. It has decreased from 3.21 (Mar 24) to 1.81, marking a decrease of 1.40.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.71. This value is below the healthy minimum of 8. It has increased from 2.17 (Mar 24) to 3.71, marking an increase of 1.54.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.87. This value is below the healthy minimum of 15. It has increased from 5.89 (Mar 24) to 8.87, marking an increase of 2.98.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.75. This value is within the healthy range. It has decreased from 14.88 (Mar 24) to 11.75, marking a decrease of 3.13.
• For Return On Assets (%), as of Mar 25, the value is 3.27. This value is below the healthy minimum of 5. It has increased from 2.07 (Mar 24) to 3.27, marking an increase of 1.20.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 0.2. It has decreased from 0.25 (Mar 24) to 0.11, marking a decrease of 0.14.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.38. This value is within the healthy range. It has decreased from 0.98 (Mar 24) to 0.38, marking a decrease of 0.60.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.90. It has decreased from 0.93 (Mar 24) to 0.90, marking a decrease of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 1.5. It has increased from 0.79 (Mar 24) to 1.18, marking an increase of 0.39.
• For Quick Ratio (X), as of Mar 25, the value is 1.10. This value is within the healthy range. It has increased from 0.62 (Mar 24) to 1.10, marking an increase of 0.48.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.81. This value is within the healthy range. It has increased from 5.60 (Mar 24) to 7.81, marking an increase of 2.21.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.51. This value is below the healthy minimum of 3. It has decreased from 2.53 (Mar 24) to 2.51, marking a decrease of 0.02.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 3. It has decreased from 1.70 (Mar 24) to 1.48, marking a decrease of 0.22.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,938.09. It has decreased from 2,593.67 (Mar 24) to 1,938.09, marking a decrease of 655.58.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.56 (Mar 24) to 0.43, marking a decrease of 0.13.
• For EV / EBITDA (X), as of Mar 25, the value is 4.59. This value is below the healthy minimum of 5. It has decreased from 4.86 (Mar 24) to 4.59, marking a decrease of 0.27.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 1. It has increased from 0.15 (Mar 24) to 0.17, marking an increase of 0.02.
• For Price / BV (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 24) to 0.41, marking a decrease of 0.01.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 1. It has increased from 0.15 (Mar 24) to 0.17, marking an increase of 0.02.
• For EarningsYield, as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has increased from 0.14 (Mar 24) to 0.21, marking an increase of 0.07.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness